Contact
Please use this form to send email to PR contact of this press release:
Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency
TO:
Please use this form to send email to PR contact of this press release:
Matinas BioPharma Announces Notification of NYSE American Continued Listing Deficiency
TO: